息肉切除术后结直肠癌风险多中心回顾性队列研究:2020英国息肉切除术后监测指南评估
结果显示低危患者无监测时结直肠癌发病率低于一般人群(SIR 0.75),高危患者则高于一般人群(SIR 1.30),首次监测后SIR为1.22。指南能准确区分高危和低危患者。
要点
- 低危患者无监测时结直肠癌发病率低于一般人群,可考虑非侵入性筛查管理。
- 高危患者无监测时结直肠癌发病率高于一般人群,一次监测结肠镜似合适。
- 高危患者首次监测后结直肠癌风险仍略高于一般人群。
核心结论
- 2020英国指南能准确将息肉切除术后患者分为高危和低危,高危者一次监测结肠镜似合适,低危者可通过非侵入性筛查管理。
研究设计与样本
- 多中心回顾性队列研究,纳入2000至2010年间在17家英国医院行结肠镜和息肉切除术的患者,随访至2017年。
主要发现
- 与一般人群相比,无监测时高风险腺瘤(伴高级别异型增生)患者结直肠癌发病率SIR为1.74(95%CI 1.21-2.42)。
- ≥2个癌前息肉且至少1个为进展期者,无监测时SIR为1.39(95%CI 1.09-1.75)。
- 低危患者(71%)无监测时SIR为0.75(95%CI 0.63-0.88),高危患者(29%)无监测时SIR为1.30(95%CI 1.03-1.62)。
- 高危患者首次监测后SIR为1.22(95%CI 0.91-1.60)。
关键数值与推荐
- 2020英国指南推荐高危患者(≥2个癌前息肉且至少1个为进展期;或≥5个癌前息肉;或≥1个非带蒂息肉≥20 mm)在3年时行监测。
- 低危患者(无上述发现)鼓励参与人群结直肠癌筛查。
临床怎么用
- 临床可按2020英国指南对息肉切除术后患者进行风险分层,高危者安排监测结肠镜,低危者建议参与人群筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Colonoscopy surveillance aims to reduce colorectal cancer (CRC) incidence after polypectomy. The 2020 UK guidelines recommend surveillance at 3 years for 'high-risk' patients with ≥2 premalignant polyps (PMPs), of which ≥1 is 'advanced' (serrated polyp (or adenoma) ≥10 mm or with (high-grade) dysplasia); ≥5 PMPs; or ≥1 non-pedunculated polyp ≥20 mm; 'low-risk' patients without these findings are instead encouraged to participate in population-based CRC screening. We examined the appropriateness of these risk classification criteria and recommendations. DESIGN: Retrospective analysis of patients who underwent colonoscopy and polypectomy mostly between 2000 and 2010 at 17 UK hospitals, followed-up through 2017. We examined CRC incidence by baseline characteristics, risk group and number of surveillance visits using Cox regression, and compared incidence with that in the general population using standardised incidence ratios (SIRs). RESULTS: Among 21 318 patients, 368 CRCs occurred during follow-up (median: 10.1 years). Baseline CRC risk factors included age ≥55 years, ≥2 PMPs, adenomas with tubulovillous/villous/unknown histology or high-grade dysplasia, proximal polyps and a baseline visit spanning 2-90 days. Compared with the general population, CRC incidence without surveillance was higher among those with adenomas with high-grade dysplasia (SIR 1.74, 95% CI 1.21 to 2.42) or ≥2 PMPs, of which ≥1 was advanced (1.39, 1.09 to 1.75). For low-risk (71%) and high-risk (29%) patients, SIRs without surveillance were 0.75 (95% CI 0.63 to 0.88) and 1.30 (1.03 to 1.62), respectively; for high-risk patients after first surveillance, the SIR was 1.22 (0.91 to 1.60). CONCLUSION: These guidelines accurately classify post-polypectomy patients into those at high risk, for whom one surveillance colonoscopy appears appropriate, and those at low risk who can be managed by non-invasive screening.
引用
- Cross AJ, Robbins EC, Pack K, et al. Colorectal cancer risk following polypectomy in a multicentre, retrospective, cohort study: an evaluation of the 2020 UK post-polypectomy surveillance guidelines. Gut. 2021. PMID: 33674342. doi:10.1136/gutjnl-2020-323411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。